Status:

COMPLETED

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes

Lead Sponsor:

Campus Bio-Medico University

Collaborating Sponsors:

National Institute of Environmental Health Sciences (NIEHS)

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

To determine whether inhaled Yabro protects against progression of COVID19-induced respiratory failure preventing the passage to non-invasive ventilation (NIV) and promotes recovery from COVID19 lung ...

Detailed Description

All patients will be treated with state of the art COVID19 treatment as per the treating clinician (Remdesivir, systemic corticosteroids, monoclonal antibodies, convalescent plasma, biologic cytokine ...

Eligibility Criteria

Inclusion

  • Age ≥ 18
  • Diagnosis of COVID19 by validated SARS-CoV-2 antigen, RT-PCR, or other molecular diagnostic assay, using an appropriate sample such as NP, nasal, oropharyngeal \[OP\], or saliva) and no alternative explanation for current clinical condition.
  • Respiratory failure requiring oxygen therapy
  • Has symptoms consistent with COVID-19, and is in non-fibroproliferative stage of disease, as determined by investigator.

Exclusion

  • Respiratory arrest or the need for immediate intubation;
  • Upper airway obstruction;
  • Facial trauma;
  • Inability to cooperate (e.g. agitation or dementia)
  • Inability to give informed consent
  • Participation in another study for COVID19 treatments
  • Deterioration due to other reasons than progressive COVID19 pneumonia per clinical judgment, e.g. pulmonary thromboembolism, heart failure, renal failure etc.
  • Palliative care or expectation that patient will not survive \> 72 hours post randomization per clinical judgment of the investigator.

Key Trial Info

Start Date :

February 26 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2021

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT04830020

Start Date

February 26 2021

End Date

September 30 2021

Last Update

March 16 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Università Campus Biomedico di Roma

Roma, Italy, 00128